Free Trial

RXO (RXO) Set to Release Earnings on Thursday

RXO logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • RXO is expected to report Q3 2026 earnings before the market opens on November 5, 2026. Analysts forecast earnings of $0.0786 per share and revenue of $1.82 billion.
  • In the prior quarter, RXO earned $0.06 per share, exceeding estimates of $0.04, while revenue rose 25% year over year to $1.77 billion.
  • Analyst sentiment is broadly cautious, with RXO carrying a consensus “Hold” rating and an average price target of $26.08; the stock recently opened at $27.60.
  • MarketBeat previews the top five stocks to own by November 1st.

RXO (NYSE:RXO - Get Free Report) is projected to issue its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect RXO to post earnings of $0.0786 per share and revenue of $1.82 billion for the quarter. Parties may review the information on the company's upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

RXO (NYSE:RXO - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. The company had revenue of $1.77 billion during the quarter, compared to analyst estimates of $1.63 billion. RXO had a negative net margin of 1.72% and a negative return on equity of 0.98%. The firm's revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter last year, the business posted $0.04 EPS. On average, analysts expect RXO to post $0.15 EPS for the current fiscal year and $0.74 EPS for the next fiscal year.

RXO Price Performance

RXO stock opened at $27.60 on Thursday. The stock has a market cap of $4.55 billion, a price-to-earnings ratio of -45.25 and a beta of 2.10. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.27 and a quick ratio of 1.27. RXO has a 1 year low of $10.43 and a 1 year high of $29.90. The firm has a 50-day moving average of $23.53 and a two-hundred day moving average of $20.89.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on RXO shares. TD Cowen raised shares of RXO from a "sell" rating to a "hold" rating and raised their target price for the stock from $17.50 to $30.25 in a research report on Monday, October 5th. UBS Group set a $19.00 price target on shares of RXO in a research note on Wednesday, September 23rd. Deutsche Bank Aktiengesellschaft set a $30.00 price target on RXO in a report on Friday, August 7th. Jefferies Financial Group cut RXO from a "buy" rating to a "hold" rating and set a $30.00 price objective on the stock. in a research note on Tuesday, October 6th. Finally, BMO Capital Markets downgraded RXO from an "outperform" rating to a "hold" rating and set a $30.25 price objective on the stock. in a report on Tuesday, October 6th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $26.08.

Read Our Latest Report on RXO

About RXO

(Get Free Report)

RXO, Inc is a transportation and logistics company that connects shippers with motor carriers and other transportation providers. The company primarily operates an asset-light business model, arranging freight transportation rather than owning a large fleet of trucks.

Its services include truckload freight brokerage, managed transportation and last-mile delivery. RXO uses technology and logistics expertise to help businesses source transportation capacity, manage shipments and coordinate deliveries across their supply chains.

RXO serves customers throughout North America, including the United States, Canada and Mexico.

Read More

Earnings History for RXO (NYSE:RXO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in RXO Right Now?

Before you consider RXO, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.

While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines